Details for Patent: 10,426,780
✉ Email this page to a colleague
Which drugs does patent 10,426,780 protect, and when does it expire?
Patent 10,426,780 protects JULUCA and is included in one NDA.
This patent has one hundred and forty-five patent family members in forty-four countries.
Summary for Patent: 10,426,780
| Title: | Antiviral therapy |
| Abstract: | The present invention relates to combinations of compounds comprising HIV integrase inhibitors and other therapeutic agents. Such combinations are useful in the inhibition of HIV replication, the prevention and/or treatment of infection by HIV, and in the treatment of AIDS and/or ARC. |
| Inventor(s): | Mark Richard Underwood |
| Assignee: | ViiV Healthcare Co |
| Application Number: | US15/366,442 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,426,780 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Dosage form; |
Drugs Protected by US Patent 10,426,780
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Viiv Hlthcare | JULUCA | dolutegravir sodium; rilpivirine hydrochloride | TABLET;ORAL | 210192-001 | Nov 21, 2017 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | TREATMENT OF HIV INFECTION | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,426,780
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2932970 | ⤷ Start Trial | CA 2018 00036 | Denmark | ⤷ Start Trial |
| European Patent Office | 2932970 | ⤷ Start Trial | PA2018013 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2932970 | ⤷ Start Trial | 300957 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2932970 | ⤷ Start Trial | 122018000125 | Germany | ⤷ Start Trial |
| European Patent Office | 2932970 | ⤷ Start Trial | 2018C/041 | Belgium | ⤷ Start Trial |
| European Patent Office | 2932970 | ⤷ Start Trial | LUC00090 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 2932970 | ⤷ Start Trial | CR 2018 00036 | Denmark | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
